Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. This subgroup researches, develops, manufactures and markets products to improve the health of people and animals.
The subgroup has four operating divisions:
- Animal Health (veterinary medicines and grooming products);
- Consumer Care (chiefly over-the-counter medicines, dietary supplements and prescription dermatology products);
- Medical Care (blood glucose monitoring devices, contrast agents, injection systems for diagnostic and therapeutic medical procedures);
- Pharmaceuticals (prescription medicines).
(As of December 31, 2014)
2 until March 31, 2015; effective April 1, 2015, Werner Baumann
Bayer HealthCare plans the transition of more than
new molecular entities into development in 2015.
Research and development expenses